冠脈支架進入千元時代

Stent prices to fall 90%

冠脈支架進入千元時代

Centralized procurement of coronary stents is expected to see prices in China fall by at least 90%.

國家組織的集中帶量採購預計將讓冠脈支架的價格下降超過9成。

The bulk-buy program is expected to make coronary stents, once priced at more than 10,000 yuan each, available to patients in Chinese hospitals for roughly 1,000 yuan for the treatment of coronary heart disease. It is estimated that the price reduction will save patients some 10.9 billion yuan a year in related expenses.

冠脈支架手術是治療冠心病的醫療手段，單個支架的價格原來在1萬元以上，經國家集中帶量採購後價格可下降至1000元左右，預計每年將爲患者節約109億元左右的相關費用。

China has more than 330 million patients with heart disease, according to a report last year by the National Center for Cardiovascular Diseases.

國家心血管病中心去年發佈的報告顯示，我國心血管病患者人數超過3.3億。

It said the number of patients receiving percutaneous coronary intervention - which uses stents to open narrowed arteries that supply heart muscle with blood - soared dramatically, from 230,000 in 2009 to more than 1 million last year.

從2009年到2019年，接受經皮冠狀動脈介入治療的患者人數從23萬例劇增至超過100萬例。經皮冠狀動脈介入治療是指爲狹窄的冠狀動脈管腔置入支架，從而改善心肌供血的治療方法。